Skip to main content
SpringerLink
Log in
Book cover

Management of Thyroid Nodules and Differentiated Thyroid Cancer pp 133–144Cite as

The Role of Surgery for Nodular Hyperthyroidism

  • Chapter
  • First Online:

  • 1422 Accesses

Abstract

The management of nodules in the setting of hyperthyroidism presents a challenge for the clinician and patient. The workup should focus on distinguishing the three main etiologies of hyperthyroidism: Graves’ disease, toxic multinodular goiter, and toxic solitary nodule. The primary imaging consists of ultrasound and radioactive iodine uptake scanning. Additional workup aims to rule out the presence of cancer in any of the nodules. This is accomplished via fine needle aspiration (FNA) biopsy. When choosing the definitive treatment strategy, surgery becomes an attractive solution because it eliminates the need for future surveillance of the nodules, alleviates compressive symptoms from the nodules or goiter, and resolves any current or future concern about thyroid cancer.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Panneerselvan R, Schneider DF, Sippel RS, Chen H. Radioactive iodine scanning is not beneficial but its use persists for euthyroid patients. J Surg Res. 2013;184(1):269–73.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Okosieme OE, Chan D, Price SA, Lazarus JH, Premawardhana LD. The utility of radioiodine uptake and thyroid scintigraphy in the diagnosis and management of hyperthyroidism. Clin Endocrinol (Oxf). 2010;72(1):122–7.

    Article  CAS  Google Scholar 

  3. Weetman AP. Grave’s disease 1835–2002. Horm Res. 2003;59 Suppl 1:114–8.

    CAS  PubMed  Google Scholar 

  4. Carnell NE, Valente WA. Thyroid nodules in Graves’ disease: classification, characterization, and response to treatment. Thyroid. 1998;8(8):647–52.

    Article  CAS  PubMed  Google Scholar 

  5. Tam AA, Kaya C, Kilic FB, Ersoy R, Cakir B. Thyroid nodules and thyroid cancer in Graves’ disease. Arq Bras Endocrinol Metabol. 2014;58(9):933–8.

    PubMed  Google Scholar 

  6. Torring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, et al. Graves’ hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab. 1996;81(8):2986–93.

    CAS  PubMed  Google Scholar 

  7. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011;17(3):456–520.

    Article  PubMed  Google Scholar 

  8. Kim WB, Han SM, Kim TY, Nam-Goong IS, Gong G, Lee HK, et al. Ultrasonographic screening for detection of thyroid cancer in patients with Graves’ disease. Clin Endocrinol (Oxf). 2004;60(6):719–25.

    Article  Google Scholar 

  9. Lee J, Nam KH, Chung WY, Soh EY, Park CS. Clinicopathologic features and treatment outcomes in differentiated thyroid carcinoma patients with concurrent Graves’ disease. J Korean Med Sci. 2008;23(5):796–801.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Nys P, Cordray JP, Sarafian V, Lefort-Mosse E, Merceron RE. Screening for thyroid cancer according to French recommendations with thyroid ultrasound in newly diagnosed Graves’ disease without palpable nodule is not useful. Ann Endocrinol (Paris). 2015;76(1):13–8.

    Article  Google Scholar 

  11. Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”–screening and overdiagnosis. N Engl J Med. 2014;371(19):1765–7.

    Article  PubMed  Google Scholar 

  12. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.

    Article  PubMed  Google Scholar 

  13. Castagna MG, Belardini V, Memmo S, Maino F, Di Santo A, Toti P, et al. Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias. J Clin Endocrinol Metab. 2014;99(9):3193–8.

    Article  CAS  PubMed  Google Scholar 

  14. Liu J, Bargren A, Schaefer S, Chen H, Sippel RS. Total thyroidectomy: a safe and effective treatment for Graves’ disease. J Surg Res. 2011;168(1):1–4.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Ozaki O, Ito K, Mimura T, Sugino K, Kitamura Y, Iwabuchi H, et al. Thyroid carcinoma after radioactive iodine therapy for Graves’ disease. World J Surg. 1994;18(4):518–21.

    Article  CAS  PubMed  Google Scholar 

  16. Wilhelm SM, McHenry CR. Total thyroidectomy is superior to subtotal thyroidectomy for management of Graves’ disease in the United States. World J Surg. 2010;34(6):1261–4.

    Article  PubMed  Google Scholar 

  17. Al-Adhami A, Snaith AC, Craig WL, Krukowski ZH. Changing trends in surgery for Graves’ disease: a cohort comparison of those having surgery intended to preserve thyroid function with those having ablative surgery. J Otolaryngol. 2013;42:37.

    Google Scholar 

  18. Feroci F, Rettori M, Borrelli A, Coppola A, Castagnoli A, Perigli G, et al. A systematic review and meta-analysis of total thyroidectomy versus bilateral subtotal thyroidectomy for Graves’ disease. Surgery. 2014;155(3):529–40.

    Article  PubMed  Google Scholar 

  19. Oltmann SC, Brekke AV, Schneider DF, Schaefer SC, Chen H, Sippel RS. Preventing postoperative hypocalcemia in patients with Graves disease: a prospective study. Ann Surg Oncol. 2015;22(3):952–8.

    Google Scholar 

  20. Elfenbein DM, Scheri R, Roman S, Sosa JA. Detection and management of cervical lymph nodes in papillary thyroid cancer. Expert Rev Endocrinol Metabol. 2013;8(4):365–78.

    Google Scholar 

  21. Mok VM, Oltmann SC, Chen H, Sippel RS, Schneider DF. Identifying predictors of a difficult thyroidectomy. J Surg Res. 2014;190(1):157–63.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ritter K, Elfenbein D, Schneider DF, Chen H, Sippel RS. Hypoparathyroidism after total thyroidectomy: incidence and resolution. J Surg Res. 2015;197(2):348–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126(3):226–31.

    Article  CAS  PubMed  Google Scholar 

  24. Berghout A, Wiersinga WM, Smits NJ, Touber JL. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med. 1990;89(5):602–8.

    Article  CAS  PubMed  Google Scholar 

  25. Gozu HI, Lublinghoff J, Bircan R, Paschke R. Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism. Mol Cell Endocrinol. 2010;322(1–2):125–34.

    Article  CAS  PubMed  Google Scholar 

  26. Martin FI, Deam DR. Hyperthyroidism in elderly hospitalised patients. Clinical features and treatment outcomes. Med J Aust. 1996;164(4):200–3.

    CAS  PubMed  Google Scholar 

  27. American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS, Doherty GM, Haugen BR, Kloos RT, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.

    Article  Google Scholar 

  28. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593–646.

    Article  PubMed  Google Scholar 

  29. Kang AS, Grant CS, Thompson GB, van Heerden JA. Current treatment of nodular goiter with hyperthyroidism (Plummer’s disease): surgery versus radioiodine. Surgery. 2002;132(6):916–23; discussion 23.

    Article  PubMed  Google Scholar 

  30. Cerci C, Cerci SS, Eroglu E, Dede M, Kapucuoglu N, Yildiz M, et al. Thyroid cancer in toxic and non-toxic multinodular goiter. J Postgrad Med. 2007;53(3):157–60.

    Article  CAS  PubMed  Google Scholar 

  31. Smith JJ, Chen X, Schneider DF, Nookala R, Broome JT, Sippel RS, et al. Toxic nodular goiter and cancer: a compelling case for thyroidectomy. Ann Surg Oncol. 2013;20(4):1336–40.

    Article  PubMed  Google Scholar 

  32. Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006;91(9):3411–7.

    Article  CAS  PubMed  Google Scholar 

  33. Chen AY, Bernet VJ, Carty SE, Davies TF, Ganly I, Inabnet 3rd WB, et al. American Thyroid Association statement on optimal surgical management of goiter. Thyroid. 2014;24(2):181–9.

    Article  PubMed  Google Scholar 

  34. Stang MT, Armstrong MJ, Ogilvie JB, Yip L, McCoy KL, Faber CN, et al. Positional dyspnea and tracheal compression as indications for goiter resection. Arch Surg. 2012;147(7):621–6.

    Article  PubMed  Google Scholar 

  35. Porterfield Jr JR, Thompson GB, Farley DR, Grant CS, Richards ML. Evidence-based management of toxic multinodular goiter (Plummer’s Disease). World J Surg. 2008;32(7):1278–84.

    Article  PubMed  Google Scholar 

  36. Abraham-Nordling M, Torring O, Hamberger B, Lundell G, Tallstedt L, Calissendorff J, et al. Graves’ disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid. 2005;15(11):1279–86.

    Article  CAS  PubMed  Google Scholar 

  37. Sztal-Mazer S, Nakatani VY, Bortolini LG, Boguszewski CL, Graf H, de Carvalho GA. Evidence for higher success rates and successful treatment earlier in Graves’ disease with higher radioactive iodine doses. Thyroid. 2012;22(10):991–5.

    Article  CAS  PubMed  Google Scholar 

  38. Schneider DF, Sonderman PE, Jones MF, Ojomo KA, Chen H, Jaume JC, et al. Failure of radioactive iodine in the treatment of hyperthyroidism. Ann Surg Oncol. 2014;21(13):4174–80.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA. 1998;280(4):347–55.

    Article  CAS  PubMed  Google Scholar 

  40. Metso S, Auvinen A, Huhtala H, Salmi J, Oksala H, Jaatinen P. Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer. 2007;109(10):1972–9.

    Article  CAS  PubMed  Google Scholar 

  41. Vidal-Trecan GM, Stahl JE, Eckman MH. Radioiodine or surgery for toxic thyroid adenoma: dissecting an important decision. A cost-effectiveness analysis. Thyroid. 2004;14(11):933–45.

    Article  PubMed  Google Scholar 

  42. Nygaard B, Hegedus L, Nielsen KG, Ulriksen P, Hansen JM. Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin Endocrinol (Oxf). 1999;50(2):197–202.

    Article  CAS  Google Scholar 

  43. Vaiman M, Nagibin A, Hagag P, Kessler A, Gavriel H. Hypothyroidism following partial thyroidectomy. Otolaryngol Head Neck Surg. 2008;138(1):98–100.

    Article  PubMed  Google Scholar 

  44. Goldstein R, Hart IR. Follow-up of solitary autonomous thyroid nodules treated with 131I. N Engl J Med. 1983;309(24):1473–6.

    Article  CAS  PubMed  Google Scholar 

  45. Wahl RA, Rimpl I, Saalabian S, Schabram J. Differentiated operative therapy of thyroid autonomy (Plummer’s disease). Exp Clin Endocrinol Diabetes. 1998;106 Suppl 4:S78–84.

    Article  CAS  PubMed  Google Scholar 

  46. van Soestbergen MJ, van der Vijver JC, Graafland AD. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves’ disease. J Endocrinol Invest. 1992;15(11):797–800.

    Article  PubMed  Google Scholar 

  47. Bonnema SJ, Bertelsen H, Mortensen J, Andersen PB, Knudsen DU, Bastholt L, et al. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab. 1999;84(10):3636–41.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of California, Irvine, Irvine, CA, USA

    Dawn M. Elfenbein MD, MPH

  2. Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, Madison, WI, USA

    David F. Schneider MD, MS

Authors
  1. Dawn M. Elfenbein MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David F. Schneider MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David F. Schneider MD, MS .

Editor information

Editors and Affiliations

  1. Endocrine Surgery, Department of Surgery, Duke University Medical Center Duke Cancer Institute, Durham, North Carolina, USA

    Sanziana A. Roman

  2. Department of Surgery, Duke University Medical Center Duke Cancer Institute, Durham, North Carolina, USA

    Julie Ann Sosa

  3. Division of Surgical Oncology and Endocrine Surgery, Vanderbilt Endocrine Surgery Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA

    Carmen C. Solórzano

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Elfenbein, D.M., Schneider, D.F. (2017). The Role of Surgery for Nodular Hyperthyroidism. In: Roman, S., Sosa, J., Solórzano, C. (eds) Management of Thyroid Nodules and Differentiated Thyroid Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-43618-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43618-0_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43616-6

  • Online ISBN: 978-3-319-43618-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation